Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4944)
All Articles published online
|
May 21, 2012 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dang HZ, Yu Y, Jiao SC. Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis. World J Gastroenterol 2012; 18(19): 2402-2407 [PMID: 22654433 DOI: 10.3748/wjg.v18.i19.2402] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i19/2402.htm |
| Number | Citing Articles |
| 1 |
Kentaro Fujiwara, Atsushi B. Tsuji, Hitomi Sudo, Aya Sugyo, Hiroki Akiba, Hiroko Iwanari, Osamu Kusano-Arai, Kouhei Tsumoto, Toshimitsu Momose, Takao Hamakubo, Tatsuya Higashi. 111In-labeled anti-cadherin17 antibody D2101 has potential as a noninvasive imaging probe for diagnosing gastric cancer and lymph-node metastasis. Annals of Nuclear Medicine 2020; 34(1): 13 doi: 10.1007/s12149-019-01408-y
|
| 2 |
Gi-Young Ha, Sung-Hyun Yang, Hye-Jin Kang, Hyo-Lak Lee, Jin Kim, Yun-Ju Kim, Hang-Jong Yu, Jong-Inn Lee, Sung-Ho Jin. Comparison of survival outcomes according of patients with metastatic gastric cancer receiving trastuzumab with systemic chemotherapy. Korean Journal of Clinical Oncology 2020; 16(2): 63 doi: 10.14216/kjco.20011
|
| 3 |
Pengfei Yu, Yanqiang Zhang, Zeyao Ye, Xiangliu Chen, Ling Huang, Yian Du, Xiangdong Cheng. <p>Treatment of Synchronous Liver Metastases from Gastric Cancer: A Single-Center Study</p>. Cancer Management and Research 2020; : 7905 doi: 10.2147/CMAR.S261353
|
| 4 |
Valentina Fanotto, Elena Ongaro, Karim Rihawi, Antonio Avallone, Nicola Silvestris, Lorenzo Fornaro, Enrico Vasile, Lorenzo Antonuzzo, Francesco Leone, Gerardo Rosati, Francesco Giuliani, Roberto Bordonaro, Mario Scartozzi, Giovanna De Maglio, Francesca V. Negri, Gianpiero Fasola, Giuseppe Aprile. HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives. Oncotarget 2016; 7(42): 69060 doi: 10.18632/oncotarget.11264
|
| 5 |
Qichun Wei, Jing Xu, Li Shen, Xianhua Fu, Bicheng Zhang, Xiaofeng Zhou, Jorgen Carlsson. HER2 expression in primary gastric cancers and paired synchronous lymph node and liver metastases. A possible road to target HER2 with radionuclides. Tumor Biology 2014; 35(7): 6319 doi: 10.1007/s13277-014-1830-3
|
| 6 |
Mi Jin Gu, Seung-Mo Hong, Soo Jin Jung. HER2 protein expression and HER2 gene amplification are infrequent in small intestinal carcinomas. Virchows Archiv 2013; 462(6): 603 doi: 10.1007/s00428-013-1425-1
|
| 7 |
Narikazu Boku. HER2-positive gastric cancer. Gastric Cancer 2014; 17(1): 1 doi: 10.1007/s10120-013-0252-z
|
| 8 |
Litong Shi, Zehua Wang, Lei Wang, Yongxu Jia, Jing Li, Yanru Qin. A Prognostic Nomogram and Heat Map to Predict Survival in Stage II/III Gastric Cancer Patients After Curative Gastrectomy Followed by Adjuvant Chemotherapy. Cancer Management and Research 2022; : 287 doi: 10.2147/CMAR.S348890
|
| 9 |
Laura Caggiari, Gianmaria Miolo, Angela Buonadonna, Debora Basile, Davide Santeufemia, Antonio Cossu, Giuseppe Palmieri, Mariangela De Zorzi, Mara Fornasarig, Lara Alessandrini, Vincenzo Canzonieri, Giovanni Lo Re, Fabio Puglisi, Agostino Steffan, Renato Cannizzaro, Valli De Re. Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype. International Journal of Molecular Sciences 2017; 19(1): 47 doi: 10.3390/ijms19010047
|
| 10 |
Sing Yu Moorcraft, Ian Chau. Investigational therapies targeting the ErbB family in oesophagogastric cancer. Expert Opinion on Investigational Drugs 2014; 23(10): 1349 doi: 10.1517/13543784.2014.930126
|
| 11 |
Jingyu Deng, Jiping Wang, Han Liang. Surgery for Gastric Cancer. 2019; : 45 doi: 10.1007/978-3-662-45583-8_2
|
| 12 |
Romulo Celli, Monica Colunga, Natalie Patel, Mehdi Djekidel, Dhanpat Jain. Metabolic Signature on 18F-FDG PET/CT, HER2 Status, and Survival in Gastric Adenocarcinomas. Journal of Nuclear Medicine Technology 2016; 44(4): 234 doi: 10.2967/jnmt.116.181479
|
| 13 |
Marina V. Nemtsova, Ekaterina B. Kuznetsova, Irina V. Bure. Chromosomal Instability in Gastric Cancer: Role in Tumor Development, Progression, and Therapy. International Journal of Molecular Sciences 2023; 24(23): 16961 doi: 10.3390/ijms242316961
|
| 14 |
Tania Pérez Cala. Factores genéticos y epigenéticos del cáncer gástrico. Actualidades Biológicas 2017; 39(106): 5 doi: 10.17533/udea.acbi.v39n106a01
|
| 15 |
Zachary Falk, Mei Bou Nasif, Nabil Fallouh. Ophthalmoplegia in a Her2+ and β-hCG+ Patient With Leptomeningeal Carcinomatosis Secondary to Gastric Adenocarcinoma. Cureus 2022; doi: 10.7759/cureus.26658
|
| 16 |
Meltem Baykara, Mustafa Benekli, Ozgur Ekinci, Sultan Cigdem Irkkan, Halit Karaca, Umut Demirci, Muhammed Bulent Akinci, Olcun Umit Unal, Faysal Dane, Fatma Paksoy Turkoz, Ozan Balakan, Eylem Pinar Eser, Selcuk Cemil Ozturk, Metin Ozkan, Berna Oksuzoglu, Alper Sevinc, Necla Demir, Hakan Harputluoglu, Bulent Yalcin, Ugur Coskun, Aytug Uner, Ahmet Ozet, Suleyman Buyukberber. Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction Cancers. Journal of Gastrointestinal Surgery 2015; 19(9): 1565 doi: 10.1007/s11605-015-2888-y
|
| 17 |
Hiroshi Yoshida, Noriko Yamamoto, Hirokazu Taniguchi, Ichiro Oda, Hitoshi Katai, Ryoji Kushima, Hitoshi Tsuda. Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma. Virchows Archiv 2014; 465(2): 145 doi: 10.1007/s00428-014-1597-3
|
| 18 |
H. Jiang, Q. Li, S. Yu, Y. Yu, Y. Wang, W. Li, Y. Cui, T. Liu. Impact of HER2 expression on outcome in gastric cancer patients with liver metastasis. Clinical and Translational Oncology 2017; 19(2): 197 doi: 10.1007/s12094-016-1523-z
|
| 19 |
Ji-wang Liang, Jian-jun Zhang, Tao Zhang, Zhi-chao Zheng. Clinicopathological and prognostic significance of HER2 overexpression in gastric cancer: a meta-analysis of the literature. Tumor Biology 2014; 35(5): 4849 doi: 10.1007/s13277-014-1636-3
|
| 20 |
A. Ieni, V. Barresi, L. Rigoli, R. A. Caruso, G. Tuccari. HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach. Disease Markers 2015; 2015: 1 doi: 10.1155/2015/234851
|
| 21 |
Yoshitomo Yanagimoto, Hiroshi Imamura, Shiro Adachi, Kazuki Odagiri, Tomono Kawase, Masafumi Yamashita, Hiroshi Takeyama, Yozo Suzuki, Masakazu Ikenaga, Junzo Shimizu, Naohiro Tomita, Keizo Dono. The effect of specimen processing time on HER2 expression in gastric cancer and esophagogastric junction cancer: a single-center retrospective observational study. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11148-y
|
| 22 |
Sung Jin Oh, Byoung Jo Suh. Metachronous Liver Metastasis Resulting from Early Gastric Carcinoma after Subtotal Gastrectomy Following Endoscopic Resection: A Case Report. Journal of Gastric Cancer 2015; 15(2): 139 doi: 10.5230/jgc.2015.15.2.139
|
| 23 |
WEIWEI QI, XIAOXIAO LI, YONGCHUN ZHANG, RUYONG YAO, WENSHENG QIU, DONGFANG TANG, JUN LIANG. Overexpression of Her-2 upregulates FoxM1 in gastric cancer. International Journal of Molecular Medicine 2014; 33(6): 1531 doi: 10.3892/ijmm.2014.1732
|
| 24 |
Fatma Senel. Clinicopathologic significance of human epidermal growth factor receptor 2 expression and gene amplification in gastric carcinoma. Journal of Cancer Research and Therapeutics 2022; 18(9): 299 doi: 10.4103/jcrt.JCRT_1810_20
|
| 25 |
Yuanyuan Wang, Bing Zhang, Ge Gao, Yinping Zhang, Qingxin Xia. GEFT protein expression in digestive tract malignant tumors and its clinical significance. Oncology Letters 2019; doi: 10.3892/ol.2019.10915
|
| 26 |
Huizi Keiko Li, Yukie Morokoshi, Satoshi Kodaira, Tamon Kusumoto, Katsuyuki Minegishi, Hiroaki Kanda, Kotaro Nagatsu, Sumitaka Hasegawa. Utility of 211At-Trastuzumab for the Treatment of Metastatic Gastric Cancer in the Liver: Evaluation of a Preclinical α-Radioimmunotherapy Approach in a Clinically Relevant Mouse Model. Journal of Nuclear Medicine 2021; 62(10): 1468 doi: 10.2967/jnumed.120.249300
|
| 27 |
Muhammad Afzal, Mohammed Amir, Muhammad Jawad Hassan, Muhammad Sikander Hussain, Muhammad Naveed Aziz, Sheeba Murad, Iram Murtaza, Mariam Anees, Aneesa Sultan. Clinical role of HER2 gene amplification and chromosome 17: a study on 154 IHC-equivocal cases of invasive breast carcinoma patients. Tumor Biology 2016; 37(7): 8665 doi: 10.1007/s13277-015-4657-7
|
| 28 |
Chiara Arienti, Sara Pignatta, Anna Tesei. Epidermal Growth Factor Receptor Family and its Role in Gastric Cancer. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01308
|
| 29 |
Xiaoxiao Li, Dongfang Tang, Yasai Yao, Weiwei Qi, Jun Liang. Clinical significance and positive correlation of FoxM1 and Her-2 expression in gastric cancer. Clinical and Experimental Medicine 2014; 14(4): 447 doi: 10.1007/s10238-013-0261-6
|
| 30 |
Kecheng Zhang, Jianxin Cui, Hongqing Xi, Shibo Bian, Liangang Ma, Weisong Shen, Jiyang Li, Ning Wang, Bo Wei, Lin Chen, Elda Tagliabue. Serum HER2 Is a Potential Surrogate for Tissue HER2 Status in Gastric Cancer: A Systematic Review and Meta-Analysis. PLOS ONE 2015; 10(8): e0136322 doi: 10.1371/journal.pone.0136322
|
| 31 |
Ryo Wada, Kenichi Hirabayashi, Nobuyuki Ohike, Eiichi Morii. New guidelines for HER2 pathological diagnostics in gastric cancer. Pathology International 2016; 66(2): 57 doi: 10.1111/pin.12390
|
| 32 |
Yu-ying Lei, Jin-yu Huang, Qiong-rui Zhao, Nan Jiang, Hui-mian Xu, Zhen-ning Wang, Hai-qing Li, Shi-bo Zhang, Zhe Sun. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature. World Journal of Surgical Oncology 2017; 15(1) doi: 10.1186/s12957-017-1132-5
|
| 33 |
Edward L Nelson. HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology. Clinical Investigation 2014; 4(8): 705 doi: 10.4155/cli.14.62
|
| 34 |
Masazumi Sakaguchi, Norihiro Shimoike, Shin Akagawa, Seiichiro Kanaya. Strategy for treatment of stage IV human epidermal growth factor 2-positive gastric cancer: a case report. Journal of Medical Case Reports 2019; 13(1) doi: 10.1186/s13256-019-2001-3
|
| 35 |
Dai Shimizu, Mitsuro Kanda, Yasuhiro Kodera. Emerging evidence of the molecular landscape specific for hematogenous metastasis from gastric cancer. World Journal of Gastrointestinal Oncology 2018; 10(6): 124-136 doi: 10.4251/wjgo.v10.i6.124
|
| 36 |
Q. Li, H. Li, H. Jiang, Y. Feng, Y. Cui, Y. Wang, Y. Ji, Y. Yu, W. Li, C. Xu, S. Yu, R. Zhuang, T. Liu. Predictive factors of trastuzumab-based chemotherapy in HER2 positive advanced gastric cancer: a single-center prospective observational study. Clinical and Translational Oncology 2018; 20(6): 695 doi: 10.1007/s12094-017-1772-5
|
| 37 |
Caroline Lum, Sophia Frentzas. Research and Clinical Applications of Targeting Gastric Neoplasms. 2021; : 317 doi: 10.1016/B978-0-323-85563-1.00010-1
|
| 38 |
Pathmanathan Rajadurai, Ho Kean Fatt, Foo Yoke Ching. Prevalence of HER2 Positivity and Its Clinicopathological Correlation in Locally Advanced/Metastatic Gastric Cancer Patients in Malaysia. Journal of Gastrointestinal Cancer 2018; 49(2): 150 doi: 10.1007/s12029-017-9921-1
|
| 39 |
David Larbi Simpong, Richard Harry Asmah, Cecilia Krampah, Patrick Kafui Akakpo, Patrick Adu, Du-Bois Asante, Simon Naporo, Andrew Anthony Adjei, Richard Kwasi Gyasi. HER-2 Protein Overexpression in Patients with Gastric and Oesophageal Adenocarcinoma at a Tertiary Care Facility in Ghana. The Scientific World Journal 2018; 2018: 1 doi: 10.1155/2018/1564150
|